Search Results - Andrew Rowland

A Physiologically Based Pharmacokinetic Model to Predict Determinants of Variability in Epirubicin Exposure and Tissue Distribution by Radwan Ansaar, Robyn Meech, Andrew Rowland

Connect to this object online.

Mechanistic Modelling Identifies and Addresses the Risks of Empiric Concentration-Guided Sorafenib Dosing by Warit Ruanglertboon, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland

Connect to this object online.

Refining and testing the diagnostic accuracy of an assessment tool (PAT-POPS) to predict admission and discharge of children and young people who attend an emergency department: pr... by Samah Riaz, Andrew Rowland, Steve Woby, Tony Long, Joan Livesley, Sarah Cotterill, Calvin Heal, Damian Roland

Connect to this object online.

Protein Isolate from <i>Parkia biglobosa</i> Seeds Improves Dyslipidaemia and Cardiac Oxidative Stress in Streptozotocin-Induced Diabetic Rats by Bolajoko Idiat Ogunyinka, Babatunji Emmanuel Oyinloye, Foluso Oluwagbemiga Osunsanmi, Unathi Kolanisi, Andrew Rowland Opoku, Abidemi Paul Kappo

Connect to this object online.

Validation of a 3-h Sampling Interval to Assess Variability in Cytochrome P450 3A Phenotype and the Impact of Induction and Mechanism-Based Inhibition Using Midazolam as a Probe Su... by Madelé van Dyk, Asha J. Kapetas, Ashley M. Hopkins, A. David Rodrigues, Manoli Vourvahis, Michael J. Sorich, Andrew Rowland

Connect to this object online.

Study of the ketohexokinase inhibitor PF‐06835919 as a clinical cytochrome P450 3A inducer: Integrated use of oral midazolam and liquid biopsy by Ruolun Qiu, Kari Fonseca, Arthur Bergman, Jian Lin, David Tess, Lauren Newman, Alia Fahmy, Zivile Useckaite, Andrew Rowland, Manoli Vourvahis, David Rodrigues

Connect to this object online.

Nuances to precision dosing strategies of targeted cancer medicines by Ashley M. Hopkins, Bradley D. Menz, Michael D. Wiese, Ganessan Kichenadasse, Howard Gurney, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich

Connect to this object online.

Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure by Kenneth H. Wills, Stephen J. Behan, Michael J. Nance, Jessica L. Dawson, Thomas M. Polasek, Ashley M. Hopkins, Madelé van Dyk, Andrew Rowland

Connect to this object online.